Press Releases

and/or
560 News Releases found
MSK Awards and Appointments October and November 2025

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Omar Abdel-Wahab Elected to the National Academy of ...
Memorial Sloan Kettering Cancer Center Issues Statement on Third Quarter 2025 Financial Results

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first three quarters of 2025:
Paul Marks Prize
Three Investigators Named Winners of Memorial Sloan Kettering Cancer Center’s 2025 Paul Marks Prize for Cancer Research

Memorial Sloan Kettering Cancer Center (MSK) will award three influential cancer researchers with this year’s Paul Marks Prize for Cancer Research. The prize, named in honor of former MSK president Paul Marks, MD, recognizes a new generation of leaders who are making significant contributions to the understanding of cancer or are improving the treatment of the disease.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center is the Best Oncology Hospital in the World according to Newsweek

Memorial Sloan Kettering Cancer Center (MSK) is ranked the number one hospital in the world for oncology according to Newsweek’s World’s Best Specialized Hospitals 2026 list.
Omar Abdel-Wahab
Memorial Sloan Kettering Cancer Center Physician-Scientist Elected to the Prestigious National Academy of Medicine

Omar Abdel-Wahab, MD, Chair of the Molecular Pharmacology Program at Sloan Kettering Institute (SKI); Evnin Family Chair in Molecular Pharmacology and Attending Physician on the Leukemia Service at Memorial Sloan Kettering Cancer Center (MSK), has been elected to the National Academy of Medicine (NAM), one of the most prestigious honors in the fields of health and medicine.
Ross Levine
Ross Levine, MD, Named Chief Scientific Officer of Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announced today that Ross Levine, MD, has been named MSK’s new Chief Scientific Officer (CSO). A renowned physician-scientist, Dr. Levine previously served as Senior Vice President of Translational Research in Memorial Hospital (MH) and holds the Edward P. Evans Endowed Chair for Myelodysplastic Syndromes at MSK.
MSK Awards and Appointments September 2025
MSK Awards and Appointments September 2025

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Maria Jasin Awarded the 2025 Peral Meister Greengard...
Vinod Balachandran, MD and Research Associate Luis A. Rojas, PhD in the Balachandran Lab.
Memorial Sloan Kettering Cancer Center and Quantoom Biosciences Sign Research License and Supply Agreement for mRNA Formulation Technology in Personalized Cancer Therapeutics

Memorial Sloan Kettering Cancer Center (MSK), one of the world’s leading institutions for cancer treatment, research, and education, and Quantoom Biosciences, a full-stack RNA technology partner have executed a non-exclusive research license and supply agreement to support the development of personalized cancer therapies using Quantoom’s proprietary lipid nanoparticle (LNP) formulation technology, Ncapsulate® QCX-002.
MSK Awards and Appointments
MSK Awards and Appointments August 2025

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Matthew Bott Joins the Lung Cancer Research Fo...
Memorial Sloan Kettering Cancer Center Issues Statement on Second Quarter 2025 Financial Results

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first two quarters of 2025: